5Kuhli C, Scharrer I, Koch F, et al. Factor Ⅶ deficiency: a thrombophilic risk factor for retinal vein occlusion. Am J Ophthal- mol, 2004,137:459-464.
6Schousboe I. Pharmacological regulation of factorⅦactivation may be a new target to control pathological coagulation. Biochem Pharmacol,2008 ,75:1007-1013.
7Yarovaya GA, Blokhina TB, Neshkova EA. Contact system. New concepts on activation mechanisms and bioregulatory functions. Bi- ochemistry (Mosc) ,2002, 67 : 13-24.
8Ishii K, Oguchi S, Moriki T, et al. Genetic analyses and expres- sion studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor Ⅶ deficiency. Blood Coagul Fibrinolysis, 2004, 15 : 367-373.
9Oguchi S, Ishii K, Moriki T, et al. Factor ⅦShizuoka, a novel mutation(Ala392Thr) identified and characterized in a patient with congenital coagulation factor Ⅶ dificiency. Thromb Res, 2005, 115: 191-197.
10Endler G, Exner M, Mannhalter C,et al. A common C > T poly- morphism at nt 46 in the promoter region of coagulation factor Ⅻ is associated with decreased factor Ⅻ activity. Thromb Res, 2001, 101:255-260.
